Short answer
FATE THERAPEUTICS INC (FATE) filed an 8-K current report with the SEC on May 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 financial results for quarter ended March 31, 2026.
FATE THERAPEUTICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results for quarter ended March 31, 2026
- Press release attached as Exhibit 99.1 with detailed results and management commentary
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other FATE THERAPEUTICS INC 8-K filings
Get the next FATE 8-K as it lands
Follow FATE for push alerts, or ask the research agent what this filing means.